Skip to content

Content Library

content library 1 CART EU

How Aldevron and Oxford Genetics have come together to advance CAR-T development.

James Brown,
VP Corporate Development,
Aldevron

Sartouris

White Paper: Advancing Next Generation Therapeutics

By Sartorius brandsIncuCyte & intellicyt

CART0TCR-EU-presentation

How to Generate Optimal-Affinity TCRs for the Clinic?

Elisa Kieback,
CEO,
T-Knife

1

Development of First Manufacturing Process to Produce CAR-Treg Cells for Clinical Use

Pierre Heimendinger,
VP Pharmaceutical Development,
TxCell

2.1

Regenerative Medicines and Cell Therapy Products: Is the NICE Therapy Products: Is the NICE Therapy

Grace Hampson,
Senior Economist
The Office of Health Economics